Literature DB >> 9863666

Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.

R A Ross1, H C Brockie, S R Fernando, B Saha, R K Razdan, R G Pertwee.   

Abstract

We have investigated the nature of cannabinoid receptors in guinea-pig small intestine by establishing whether this tissue contains cannabinoid receptors with similar binding properties to those of brain CB1 receptors. The cannabinoids used were the CB1-selective antagonist SR141716A, the CB2-selective antagonist SR144528, the novel cannabinoid receptor ligand, 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol (O-1184), and the agonists CP55940, which binds equally well to CB1 and CB2 receptors, and WIN55212-2, which shows marginal CB2 selectivity. [3H]-CP55940 (1 nM) underwent extensive specific binding both to forebrain membranes (76.3%) and to membranes obtained by sucrose density gradient fractionation of homogenates of myenteric plexus-longitudinal muscle of guinea-pig small intestine (65.2%). Its binding capacity (Bmax) was higher in forebrain (4281 fmol mg(-1)) than in intestinal membranes (2092 fmol mg(-1)). However, the corresponding KD values were not significantly different from each other (2.29 and 1.75 nM respectively). Nor did the Ki values for its displacement by CP55940, WIN55212-2, O-1184, SR141716A and SR144528 from forebrain membranes (0.87, 4.15, 2.85, 5.32 and 371.9 respectively) differ significantly from the corresponding Ki values determined in experiments with intestinal membranes (0.99, 5.03, 3.16, 4.95 and 361.5 nM respectively). The Bmax values of [3H]-CP55940 and [3H]-SR141716A in forebrain membranes did not differ significantly from each other (4281 and 5658 fmol mg(-1)) but were both greater than the Bmax of [3H]-WIN55212-2 (2032 fmol mg(-1)). O-1184 (10 or 100 nM) produced parallel dextral shifts in the log concentration-response curves of WIN55212-2 and CP55940 for inhibition of electrically-evoked contractions of the myenteric plexus-longitudinal muscle preparation, its KD values being 0.20 nM (against WIN55212-2) and 0.89 nM (against CP55940). We conclude that cannabinoid binding sites in guinea-pig small intestine closely resemble CB1 binding sites of guinea-pig brain and that 0-1184 behaves as a cannabinoid receptor antagonist in the guinea-pig myenteric plexus-longitudinal muscle preparation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863666      PMCID: PMC1565708          DOI: 10.1038/sj.bjp.0702204

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.

Authors:  A A Izzo; N Mascolo; M Tonini; F Capasso
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 2.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 3.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

4.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

5.  Gαs signalling of the CB1 receptor and the influence of receptor number.

Authors:  David B Finlay; Erin E Cawston; Natasha L Grimsey; Morag R Hunter; Anisha Korde; V Kiran Vemuri; Alexandros Makriyannis; Michelle Glass
Journal:  Br J Pharmacol       Date:  2017-06-19       Impact factor: 8.739

6.  Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine.

Authors:  A A Coutts; N Brewster; T Ingram; R K Razdan; R G Pertwee
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Exp Neurol       Date:  2006-10-11       Impact factor: 5.330

8.  Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors.

Authors:  R A Ross; T M Gibson; L A Stevenson; B Saha; P Crocker; R K Razdan; R G Pertwee
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 9.  Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).

Authors:  Hester van Diepen; Eberhard Schlicker; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-25       Impact factor: 3.000

Review 10.  Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

Authors:  Patricia H Reggio
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.